| Particulars |
|
|
|
|
Company Name
| Fredun Pharmaceuticals Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
16.54 |
B.V. (₹) |
163.10 |
| Sales(₹ Cr.) |
635.47 |
NP (₹ Cr.) |
33.21 |
| NP Var% |
60.00 |
Div% |
7.00 |
| CPS(₹) |
24.90 |
EPS (₹) |
20.10 |
| Traded Value(₹ Lakhs) |
167.46 |
52 Week High |
999.00 |
| 52 Week Low |
300.00 |
Price BSE |
895.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
1,480.49 |
| P/C Ratio |
36.00 |
P/E Ratio |
44.60 |
| Price Vs.BV |
5.49 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
210.41 |
| NP(₹ Cr.) |
11.07 |
NP Var % |
56.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
388.30 |
| OPM |
0.00 |
NP |
17.69 |
| NP Var% |
59.59 |
EPS |
20.08 |
| PE |
44.58 |
|
|